Jay Portnoy, MD, Rolin L. Wade, MS, Catherine Kessler, PhD

Slides:

Advertisements

Similar presentations

The Journal of Allergy and Clinical Immunology: In Practice

Advertisements

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists Michael H. Land, MD, Julie Wang, MD

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey Whitney.

Wet Wrap Therapy in Children with Moderate to Severe Atopic Dermatitis in a Multidisciplinary Treatment Program Noreen Heer Nicol, PhD, RN, FNP, Mark.

Von Ta, MD, Andrew A. White, MD

Advances in Diagnosing Peanut Allergy

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study Eli O. Meltzer, MD, Paul.

The Natural History of Food Allergy

Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients Eli O. Meltzer, MD, Judith.

Auvi-Q Versus EpiPen: Preferences of Adults, Caregivers, and Children

Niti Y. Chokshi, MD, Dipika Patel, MD, Carla M. Davis, MD

Wells Syndrome with Bullous Lesions

Fanny Legrand, PhD, PharmD, Amy D. Klion, MD

Management of Hypersensitivity Reactions to Carboplatin and Paclitaxel in an Outpatient Oncology Infusion Center: A 5-Year Review Aleena Banerji, MD,

Desensitization to Chemotherapeutic Agents

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy

Anatomic and anthropometric determinants of intramuscular versus subcutaneous administration in children with epinephrine autoinjectors Daniel C. Bewick,

Marcus Shaker, MD, MS, Tsuzumi Kanaoka, BA, Robert G. P

Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation: Exploratory Analysis Marta Ferrer, MD, PhD, Ana Giménez-Arnau,

Practice Notes from the AAAI

An Infant with Atopic Dermatitis and Itching After Ingestion of Milk

Childhood Asthma-Predictive Phenotype

Paul D. Thompson, MD, John Rubino, MD, Matthew J. Janik, MD, Diane E

Comparative Effectiveness of Budesonide-Formoterol Combination and Fluticasone- Salmeterol Combination for Asthma Management: A United States Retrospective.

Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life Bradley E. Chipps, MD, Tmirah Haselkorn, PhD, Karin Rosén, MD, PhD,

Melkersson-Rosenthal Syndrome

Validation of the Pregnancy Asthma Control Test

Evaluation of Food Allergy in Patients with Atopic Dermatitis

Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies Jolan E. Walter, MD, PhD, Jocelyn.

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey Whitney.

The Mastocytosis Society Survey on Mast Cell Disorders: Patient Experiences and Perceptions Susan Jennings, PhD, Nancy Russell, DrPH, Blair Jennings,

Advances in Diagnosing Peanut Allergy

Erythematous Candidiasis

Nonadherence to Asthma Treatment: Getting Unstuck

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study Thomas B. Casale, MD, Allan.

The Journal of Allergy and Clinical Immunology: In Practice

Thys van der Molen, MD, PhD, Monica Fletcher, MSc, David Price, FRCGP

Consistently very poorly controlled asthma is associated with greater activity and school impairment in children with severe or difficult-to-treat asthma

Value of a Second Dose of Epinephrine During Anaphylaxis: A Patient/Caregiver Survey T. Ted Song, DO, Duncan Brown, PhD, Martin Karjalainen, MD, Ulrike.

Pitfalls and peculiarities in chlorhexidine allergy

Fatal Anaphylaxis: Mortality Rate and Risk Factors

Penicillin Skin Testing Is a Safe and Effective Tool for Evaluating Penicillin Allergy in the Pediatric Population Stephanie J. Fox, MD, Miguel A. Park,

Change in Asthma Control Over Time: Predictors and Outcomes

Phillip Lieberman, MD, Michael Tankersley, MD

The Emperor Has No Symptoms: The Risks of a Blanket Approach to Using Epinephrine Autoinjectors for All Allergic Reactions Paul J. Turner, FRACP, PhD,

Effects of Mometasone, Fluticasone, and Montelukast on Bone Mineral Density in Adults with Asthma Jorge Maspero, MD, Vibeke Backer, DMSci, MD, Ruji Yao,

News & Notes Journal of Allergy and Clinical Immunology

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

The Management of Eosinophilic Esophagitis

Phillip Lieberman, MD, David Golden, MD

Melkersson-Rosenthal Syndrome

Mapping the Asthma Care Process: Implications for Research and Practice Alexandra Lelia Dima, PhD, Marijn de Bruin, PhD, Eric Van Ganse, MD, PhD, FRCP

Sinonasal Papillomas and Natural Killer–Cell Deficiency

Sharon Seth, MD, David A. Khan, MD

Cephalosporin Side Chain Cross-reactivity

Evaluation of Allergen Immunotherapy

Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency Phil Lieberman, MD, John Routes, MD The Journal.

Administration of Intravenous Immunoglobulin to a Patient with Hypogammaglobulinemia and Anti-IgA Antibodies Phillip Lieberman, MD, Rima Rachid, MD

News & Notes Journal of Allergy and Clinical Immunology

Reply The Journal of Allergy and Clinical Immunology: In Practice

Von Ta, MD, Andrew A. White, MD

Practice Notes from the AAAI

Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012 Peter A. Lio, MD, Margaret.

Footnotes1 Journal of Allergy and Clinical Immunology

What Is Chronic Cough? Terminology

Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma Stanley J. Szefler, MD, Lars-Goran Carlsson,

Pedro Giavina-Bianchi, MD, PhD, Shih-Wen Huang, MD

News & Notes Journal of Allergy and Clinical Immunology

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Presentation transcript:

Patient Carrying Time, Confidence, and Training with Epinephrine Autoinjectors: The RACE Survey Jay Portnoy, MD, Rolin L. Wade, MS, Catherine Kessler, PhD The Journal of Allergy and Clinical Immunology: In Practice DOI: 10.1016/j.jaip.2019.03.021 Copyright © 2019 The Authors Terms and Conditions

Figure 1 Respondent disposition. ∗Reminder letters were also mailed to Auvi-Q patients (n = 5,128) to help achieve recruitment goal. †To avoid overenrollment, the online survey and call center became inactive once the targeted sample size (N = 1,000) was reached. The Journal of Allergy and Clinical Immunology: In Practice DOI: (10.1016/j.jaip.2019.03.021) Copyright © 2019 The Authors Terms and Conditions

Figure 2 Likelihood of patients carrying Auvi-Q all the time during the last 7 days vs EpiPen. N value for children (n = 697) does not match the total population of children in the study (n = 702) because of the exclusion from the model of 5 children with missing age-group data. See Tables E4 to E6 for results on all model parameters. The Journal of Allergy and Clinical Immunology: In Practice DOI: (10.1016/j.jaip.2019.03.021) Copyright © 2019 The Authors Terms and Conditions

Figure 3 Number of days the EAI was carried in the previous 7 days. LS, Least squares. N value for children (n = 697) does not match the total population of children in the study (n = 702) because of the exclusion of 5 children with missing age-group data. The Journal of Allergy and Clinical Immunology: In Practice DOI: (10.1016/j.jaip.2019.03.021) Copyright © 2019 The Authors Terms and Conditions

Figure 4 Confidence in using Auvi-Q vs EpiPen correctly: “Very Confident.” See Tables E7 to E9 for results on all model parameters. ∗Responses shown for parent/guardian confidence about correctly using the EAI on their child. The Journal of Allergy and Clinical Immunology: In Practice DOI: (10.1016/j.jaip.2019.03.021) Copyright © 2019 The Authors Terms and Conditions

Figure 5 Clarity of instructions and training for Auvi-Q vs EpiPen. N value for children (n = 697) does not match the total population of children in the study (n = 702) because of the exclusion from the model of 5 children with missing age-group data. See Tables E10 to E17 for results on all model parameters. ∗Model for finding trainer helpful on EAI use could not be fit because of the extremely low number of “No” responses in children. The Journal of Allergy and Clinical Immunology: In Practice DOI: (10.1016/j.jaip.2019.03.021) Copyright © 2019 The Authors Terms and Conditions